<META charset="Unicode">
<meta name="description" content="Design Qualification (DQ) is the process of checking if GMP requirements and risk mitigation measures defined in RA are implemented in design/specifications."/>
<html lang="en">
<head>
	<link rel="alternate" hreflang="ru" href="http://www.pharmagroup.ee/03_validation/03_dq_rus.html">
	<link rel="shortcut icon" href="../pics/pgb_icon_16-64.ico" type="image/x-icon">
	<title>DQ | Pharma Group Baltic - Pharmaceutical Engineering, GMP-Consulting and Validation, GMP-Monitoring System Tarqvara® (EMS)</title>
</head>
<frameset rows="120,*">
	<frame src="../f_top.html" name="f_top" scrolling=no frameborder=0 framespacing=0 marginheight=0 noresize>
	<frameset cols="150,*" name="f_bottom">
		<frameset rows="60,*">
			<frame src="../f_left_top.html" name="f_left_top" scrolling=no frameborder=0 framespacing=0 marginheight=0 marginwidth=0 noresize>
			<frame src="../f_left_eng.html" name="f_left" scrolling=no frameborder=0 framespacing=0 marginheight=0 marginwidth=10 noresize>
		</frameset>
		<frame src="03_dq_eng_c.html" name="f_right" frameborder=0 framespacing=0 marginheight=0 marginwidth=0  noresize>
	</frameset>
	
	<noframes>
		<font face="Microsoft Sans Serif, Sans Serif, Arial" >
			<BR>
			<TABLE width=80% align=center>
				<TR>
					<TD>
						<font size=6 color=#100080><b>Design Qualification (DQ)</b></font><BR><BR>		
					</TD>
				</TR>
				<TR>
					<TD>		
						<img src="../pics/validation.png" align=right hspace=20 vspace=10>
						<font size=4 color=#8B8B8B>
						<p align=justify>
						After receiving from the supplier the final specifications that are corrected in accordance to the results of Risk Analysis (RA) and developed User Requirements Specification (URS), Design Qualification (DQ) can be conducted. In the course of Design Qualification (DQ) the implementation of GMP requirements in proposed design is checked. DQ is the last step which focuses on check of documentation only. After DQ is successfully completed, the order is placed and the equipment is manufactured. It is necessary to make possible efforts that all equipment modifications are performed at the stage of DQ. Any modifications to the equipment after its manufacturing has already started will lead to financial losses.
						<p align=justify>
						Very often RA and DQ steps are combined. Carefully conducted RA significantly simplifies DQ activities.
						<p><b>Pharma Group Baltic offers:</b></p>
						<ul>
							<img src=../bullet.png>Assistance/support in development of DQ Protocols by the Clients specialists</img>
							<p><img src=../bullet.png>Checking DQ Protocols developed by the Clients specialists</img>
							<p><img src=../bullet.png>Development of DQ Protocols by Pharma Group Baltic specialists</img>
							<p><img src=../bullet.png>Assistance/support in execution of DQ</img>
							<p><img src=../bullet.png>Execution of DQ by Pharma Group Baltic specialists</img>
							<p><img src=../bullet.png>Checking DQ Reports developed by the Clients specialists</img>
						</ul>
						</font>
					</TD>
				</TR>
			</TABLE>
		</font>
	</noframes>

</frameset>
</html>